ProQR Therapeutics N.V. buy BiotechBee
Start price
17.01.23
/
70%
€3.24
Target price
31.12.25
€5.00
Performance (%)
-41.09%
End price
05.05.23
€1.91
Summary
This prediction ended on 05.05.23 with a price of €1.91. Massive losses of -41.09% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
ProQR Therapeutics N.V. | 6.254% | 6.254% | 42.057% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to BiotechBee what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
Buy mit Kursziel 5,0
In the thread Trading ProQR Therapeutics N.V.
Buy beendet
Stopped prediction by BiotechBee for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€0.81
07.09.22
07.09.22
€2.00
31.12.24
31.12.24
72.58%
09.12.22
09.12.22
Could be very worthwhile Investment >20% year